Search
for
Sort by
Research 721–750 of 1000+
- Formulation and characterisation of resveratrol-loaded nanostructured lipid carriers for use in combination with scalp cooling therapy to mitigate chemotherapy-induced follicular cytotoxicity and hair loss
- A comprehensive review of etiology, pathophysiologyepidemiology, and management of hair loss and its correlation with COVID-19
- Pericardial, pleural effusion and anasarca: A rare complication of low-dose oral minoxidil for hair loss
- Chemotherapy-Induced Alopecia in Breast Cancer Patients: Treatment-Specific Incidence and Risk of Persistent Hair Loss
- Placental Extracts, Proteins, and Hydrolyzed Proteins as Active Ingredients in Cosmetic Preparations for Hair Loss: A Systematic Review of Available Clinical Evidence
- Characteristics of Hypertrichosis Induced by 24-week Low-dose (5 mg Daily) Oral Minoxidil in Male Pattern Hair Loss Treatment
- Alterations in androgen conjugate levels in women and men with alopecia
- Permanent Alopecia After Systemic Chemotherapy: A Clinicopathological Study of 10 Cases
- Oral Tofacitinib and Systemic Corticosteroids, Alone or in Combination, in Patients With Moderate-to-Severe Alopecia Areata: A Retrospective Study
- ORAL TOFACITINIB IN MODERATE AND SEVERE ALOPECIA AREATA: CASE SERIES OF 14 PATIENTS
- Tumor Necrosis Factor in Sepsis
- “‘You lose your hair, what’s the big deal?’ I was so embarrassed, I was so self-conscious, I was so depressed:” a qualitative interview study to understand the psychosocial burden of alopecia areata
- Comparison of Dermatology Life Quality Index Scores in Adults and Adolescents with Alopecia Areata
- 42004 Scalp, eyebrow, and eyelash hair regrowth with continued ritlecitinib treatment among patients with alopecia areata without target efficacy response at Week 24: post hoc analysis of the ALLEGRO phase 2b/3 study
- Androgen-Related Alopecia and Infertility: Impact of Lifestyle Modifications
- Alopecia: the questions we need to answer
- Dermatopathology Workshop Summary, Berlin 2004
- XIAP Stabilizes DDRGK1 to Promote ER‐Phagy and Protects Against Noise‐Induced Hearing Loss
- Cutaneous Side Effects of Chemotherapy and Radiotherapy
- The Invisible Impact of a Visible Disease: Psychosocial Impact of Alopecia Areata
- Physiological Skin Changes During Pregnancy
- Hair Cortisol in Sheltered Cows and Its Association with Other Welfare Indicators
- Alopecia Possibly Secondary to Topical Ophthalmic β-Blockers
- Pattern Alopecia during Hormonal Anticancer Therapy in Patients with Breast Cancer
- Chemotherapy-Induced Alopecia
- Hormone replacement therapy and the skin
- Estrogens and the skin
- Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study
- Efficacy and safety of mycophenolate mofetil for lichen planopilaris
- The Role of Micronutrients in Alopecia Areata: A Review